David Geffen School of Medicine, University of California, Los Angeles, 10940 Wilshire Blvd, Ste 700, Los Angeles, CA 90024, USA.
Prev Chronic Dis. 2013;10:E16. doi: 10.5888/pcd10.120150.
Investigators from the University of California, Los Angeles (UCLA), and members of the leadership and data analysis teams at UnitedHealthcare (UHC) are partnering to evaluate the Diabetes Health Plan (DHP), an innovative disease-specific insurance product designed by UHC specifically for patients with prediabetes or diabetes. The DHP provides improved access to care management, telephone coaching, and enhanced Internet-based communication with enrollees. The evaluation will use a quasi-experimental design, comparing patients from employer groups that offer the DHP with patients from groups that do not, to determine the effect of the DHP on incidence of diabetes, adherence to metformin, and costs of care among patients with prediabetes. Other factors studied will be cardiovascular risk factor control, adherence to preventive services, health care use, and costs of care among patients with existing diabetes.
来自加利福尼亚大学洛杉矶分校(UCLA)的研究人员与联合健康保险(UHC)的领导层和数据分析团队成员合作,对糖尿病健康计划(DHP)进行评估。这是一款由 UHC 专门为糖尿病前期或糖尿病患者设计的创新型疾病特定保险产品。DHP 提供了更好的护理管理、电话辅导以及与参保人员加强互联网沟通的机会。该评估将采用准实验设计,将提供 DHP 的雇主群体的患者与不提供 DHP 的雇主群体的患者进行比较,以确定 DHP 对糖尿病前期患者糖尿病发病率、二甲双胍依从性和护理成本的影响。还将研究其他因素,包括心血管风险因素控制、预防服务依从性、医疗保健使用以及现有糖尿病患者的护理成本。